The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders
Open accessAbstract
The molecular basis for the majority of cases of autism spectrum disorders (ASD) remains unknown. We tested the hypothesis that ASD have an epigenetic cause by performing DNA methylation profiling of five CpG islands (CGI-1 to CGI-5) in the SHANK3 gene in postmortem brain tissues from 54 ASD patients and 43 controls. We found significantly increased overall DNA methylation (epimutation) in three intragenic CGIs (CGI-2, CGI-3 and CGI-4). The increased methylation was clustered in the CGI-2 and CGI-4 in ∼15% of ASD brain tissues. SHANK3 has an extensive array of mRNA splice variants resulting from combinations of five intragenic promoters and alternative splicing of coding exons. Altered expression and alternative splicing of SHANK3 isoforms were observed in brain tissues with increased methylation of SHANK3 CGIs in ASD brain tissues. A DNA methylation inhibitor modified the methylation of CGIs and altered the isoform-specific expression of SHANK3 in cultured cells. This study is the first to find altered methylation patterns in SHANK3 in ASD brain samples. Our finding provides evidence to support an alternative approach to investigating the molecular basis of ASD. The ability to alter the epigenetic modification and expression of SHANK3 by environmental factors suggests that SHANK3 may be a valuable biomarker for dissecting the role of gene and environment interaction in the etiology of ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and increased levels of SHANK3 DNA methylation, corresponding to decreased isoform-specific expression of SHANK3, have been observed in postmortem brain tissues of ASD patients compared with neurotypical control tissues [ 162 ].”
From DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders? (2016) · cites this paper as [162]
In the citing paper
“SHANK3 expression in brain and other tissues is regulated by DNA methylation [ 161 , 162 ], and increased levels of SHANK3 DNA methylation, corresponding to decreased isoform-specific expression of SHANK3, have been observed in postmortem brain tissues of ASD patients compared with neurotypical control tissues [ 162 ].”
From DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders? (2016) · cites this paper as [162]
In the citing paper
“recent reports have begun to link individual microexons with neurodevelopmental disorders, including ASD (Zhu et al., 2014), schizophrenia (Ovadia and Shifman, 2011) and epilepsy (Rusconi et al., 2014)”
From A Highly Conserved Program of Neuronal Microexons Is Misregulated in Autistic Brains (2014) · cites this paper as Zhu et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG islands and the regulation of transcription
Deaton, A. M., & Bird, A. (2011) · Genes & Development · doi:10.1101/gad.2037511 · Cited by 3,187
Epigenetic Reprogramming in Mammalian Development
Reik, W., Dean, W., & Walter, J. (2001) · Science · doi:10.1126/science.1063443 · Cited by 3,078
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866
Conserved role of intragenic DNA methylation in regulating alternative promoters
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010) · Nature · doi:10.1038/nature09165 · Cited by 1,743
Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492
The Epidemiology of Autism Spectrum Disorders
Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., Mandell, D. S., Miller, L. A., Pinto-Martin, J., Reaven, J., et al. (2007) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144007 · Cited by 1,228
Maternal epigenetics and methyl supplements affect agouti gene expression in A vy /a mice
Wolff, G. L., Kodell, R. L., Moore, S. R., & Cooney, C. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.949 · Cited by 1,057
Research works printed but not linked: 1
- Phelan, 2007, Gene Reviews
Cited by
Sorted by citations
A Highly Conserved Program of Neuronal Microexons Is Misregulated in Autistic Brains
Irimia, M., Weatheritt, R. J., Ellis, J. D., Parikshak, N. N., Gonatopoulos-Pournatzis, T., Babor, M., Quesnel-Vallières, M., Tapial, J., Raj, B., O’Hanlon, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.035 · Cited by 693
“Consistent with this view, recent reports have begun to link individual microexons with neurodevelopmental disorders, including ASD (Zhu et al., 2014), schizophrenia (Ovadia and Shifman, 2011), and epilepsy (Rusconi et al.”
BackgroundAutistic spectrum disorders: A review of clinical features, theories and diagnosis
Fakhoury, M. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.04.003 · Cited by 227
Sala, C., Vicidomini, C., Bigi, I., Mossa, A., & Verpelli, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13232 · Cited by 182
Keil, K. P., & Lein, P. J. (2016) · Environmental Epigenetics · doi:10.1093/eep/dvv012 · Cited by 167
Wang, X., Xu, Q., Bey, A. L., Lee, Y., & Jiang, Y. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-30 · Cited by 173
Self-citationThe landscape of DNA methylation amid a perfect storm of autism aetiologies
Ciernia, A. V., & LaSalle, J. M. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.41 · Cited by 168
Fetit, R., Hillary, R. F., Price, D. J., & Lawrie, S. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.014 · Cited by 148
Bhandari, R., Paliwal, J. K., & Kuhad, A. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_4 · Cited by 167
Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder
Yoon, S. H., Choi, J., Lee, W. Y., & Do, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040966 · Cited by 175
Lee, J., Chung, C., Ha, S., Lee, D., Kim, D. Y., Kim, H., & Kim, E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00094 · Cited by 153
Speed, H. E., Kouser, M., Xuan, Z., Reimers, J. M., Ochoa, C. F., Gupta, N. M., Liu, S., & Powell, C. M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3125-14.2015 · Cited by 148
Epigenetic Regulations in Neuropsychiatric Disorders
Kuehner, J. N., Bruggeman, E. C., Wen, Z., & Yao, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00268 · Cited by 144
DNA Methylation and Susceptibility to Autism Spectrum Disorder
Tremblay, M. W., & Jiang, Y. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-120417-091431 · Cited by 139
Self-citationEpigenetic Research in Neuropsychiatric Disorders: the “Tissue Issue”
Bakulski, K. M., Halladay, A., Hu, V. W., Mill, J., & Fallin, M. D. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0083-4 · Cited by 127
Epigenetics of Autism Spectrum Disorder
Siu, M. T., & Weksberg, R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-53889-1_4 · Cited by 121
Nardone, S., & Elliott, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00329 · Cited by 138
Cattane, N., Richetto, J., & Cattaneo, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.001 · Cited by 129
Epigenetics in eating disorders: a systematic review
Hübel, C., Marzi, S. J., Breen, G., & Bulik, C. M. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0254-7 · Cited by 116
Lee, E., Lee, H., Huang, T., Chung, C., Shin, W., Kim, K., Koh, J., Hsueh, Y., & Kim, E. (2015) · Nature Communications · doi:10.1038/ncomms8168 · Cited by 110
Christensen, N. R., Čalyševa, J., Fernandes, E. F. A., Lüchow, S., Clemmensen, L. S., Haugaard‐Kedström, L. M., & Strømgaard, K. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800143 · Cited by 114
Drapeau, E., Riad, M., Kajiwara, Y., & Buxbaum, J. D. (2018) · eNeuro · doi:10.1523/eneuro.0046-18.2018 · Cited by 111
Case-control meta-analysis of blood DNA methylation and autism spectrum disorder
Andrews, S. V., Sheppard, B. K., Windham, G. C., Schieve, L. A., Schendel, D., Croen, L., Chopra, P., Alisch, R. S., Newschaffer, C. J., Warren, S. T., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0224-6 · Cited by 106
Prospects for the development of epigenetic drugs for CNS conditions
Szyf, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4580 · Cited by 96
The Interplay between DNA Methylation, Folate and Neurocognitive Development
Irwin, R. E., Pentieva, K. D., Cassidy, T., Lees‐Murdock, D. J., McLaughlin, M., Prasad, G., McNulty, H., & Walsh, C. P. (2016) · Epigenomics · doi:10.2217/epi-2016-0003 · Cited by 98
Zhao, H., Tu, Z., Xu, H., Yan, S., Yan, H., Zheng, Y., Yang, W., Zheng, J., Li, Z., Tian, R., et al. (2017) · Cell Research · doi:10.1038/cr.2017.95 · Cited by 94
Self-citationDelling, J. P., & Boeckers, T. M. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09397-8 · Cited by 104
Coupland, K., Kim, W. S., Halliday, G. M., Hallupp, M., Dobson‐Stone, C., & Kwok, J. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157924 · Cited by 91
An Update on the Epigenetics of Psychotic Diseases and Autism
Abdolmaleky, H. M., Zhou, J., & Thiagalingam, S. (2015) · Epigenomics · doi:10.2217/epi.14.85 · Cited by 79
Wei, H., Liang, F., Meng, G., Nie, Z., Zhou, R., Cheng, W., Wu, X., Feng, Y., & Wang, Y. (2016) · Scientific Reports · doi:10.1038/srep33402 · Cited by 70
Choi, S., Pang, K., Kim, J. Y., Ryu, J. R., Kang, H., Liu, Z., Kim, W.-K., Sun, W., Kim, H., & Han, K. (2015) · Molecular Brain · doi:10.1186/s13041-015-0165-3 · Cited by 72
An autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function
Wang, L., Pang, K., Han, K., Adamski, C. J., Wang, W., He, L.-J., Lai, J. K. H., Bondar, V. V., Duman, J. G., Richman, R., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0324-x · Cited by 70
Li, T., Liu, Q., Garza, N., Kornblau, S. M., & Jin, V. X. (2018) · Genome Medicine · doi:10.1186/s13073-018-0538-1 · Cited by 63
Behnia, F., Parets, S. E., Kechichian, T. B., Yin, H., Dutta, E. H., Saade, G. R., Smith, A. K., & Menon, R. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.02.011 · Cited by 59
Chana, G., Laskaris, L., Pantelis, C., Gillett, P., Testa, R., Zantomio, D., Burrows, E. L., Hannan, A. J., Everall, I., & Skafidas, E. S. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.05.009 · Cited by 58
Locus-specific DNA methylation of Mecp2 promoter leads to autism-like phenotypes in mice
Lu, Z., Liu, Z., Mao, W., Wang, X., Zheng, X., Chen, S., Cao, B., Huang, S., Zhang, X., Zhou, T., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2290-x · Cited by 52
Self-citationEpigenetic Mechanisms in Autism Spectrum Disorder
Zhubi, A., Cook, E. H., Guidotti, A., & Grayson, D. R. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801311-3.00006-8 · Cited by 56
Merging Data from Genetic and Epigenetic Approaches to Better Understand Autistic Spectrum Disorder
Grayson, D. R., & Guidotti, A. (2015) · Epigenomics · doi:10.2217/epi.15.92 · Cited by 51
Genetic diagnosis of autism spectrum disorders: The opportunity and challenge in the genomics era
Jiang, Y., Wang, Y., Xu, X., Choy, K. W., Pursley, A. N., & Cheung, S. W. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.910747 · Cited by 47
Self-citationZhao, Y., Jaber, V. R., LeBeauf, A., Sharfman, N. M., & Lukiw, W. J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00028 · Cited by 44
SpliceTransformer predicts tissue-specific splicing linked to human diseases
You, N., Liu, C., Gu, Y., Wang, R., Jia, H., Zhang, T., Jiang, S., Shi, J., Chen, M., Guan, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53088-6 · Cited by 48
Epigenetic Regulation of Infant Neurobehavioral Outcomes
Lesseur, C., Paquette, A. G., & Marsit, C. J. (2014) · Medical Epigenetics · doi:10.1159/000361026 · Cited by 46
Yoo, Y.-E., Yoo, T., Lee, S., Lee, J., Kim, D., Han, H.-M., Bae, Y.-C., & Kim, E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00155 · Cited by 41
Altered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats
Jacot-Descombes, S., Keshav, N. U., Dickstein, D. L., Wicinski, B., Janssen, W. G. M., Hiester, L. L., Sarfo, E. K., Warda, T., Fam, M. M., Harony-Nicolas, H., et al. (2020) · Molecular Autism · doi:10.1186/s13229-020-00393-8 · Cited by 41
Targeting epigenetic dysregulation in autism spectrum disorders
Herrera, M. L., Paraíso‐Luna, J., Bustos-Martínez, I., & Barco, Á. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.06.004 · Cited by 46
Interactions Between Genetics, Lifestyle, and Environmental Factors for Healthcare
Lin, Y., Chen, J., & Shen, B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5717-5_8 · Cited by 40
SHANK genes in autism: Defining therapeutic targets
Mossa, A., Giona, F., Pagano, J., Sala, C., & Verpelli, C. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.019 · Cited by 40
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia
Moos, W. H., Maneta, E., Pinkert, C. A., Irwin, M. H., Hoffman, M. E., Faller, D. V., & Steliou, K. (2016) · Drug Development Research · doi:10.1002/ddr.21295 · Cited by 41
Koufaris, C., & Sismani, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048699 · Cited by 35
de Lima, T. A., Zuanetti, P. A., Nunes, M. E. N., & Hamad, A. P. A. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-022-00629-y · Cited by 46
Parrella, N.-F., Hill, A. T., Dipnall, L. M., Loke, Y. J., Enticott, P. G., & Ford, T. C. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.11.014 · Cited by 33
Genetic architecture, epigenetic influence and environment exposure in the pathogenesis of Autism
Yu, L., Wu, Y., & Wu, B.-L. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4941-1 · Cited by 31
García‐Ortiz, M. V., de la Torre‐Aguilar, M. J., Morales‐Ruíz, T., Gómez-Fernández, A., Flores‐Rojas, K., Gil‐Campos, M., Martín-Borreguero, P., Ariza, R. R., Roldán‐Arjona, T., & Pérez-Navero, J. L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.685310 · Cited by 31
Liu, C., Peng, X., Hu, C.-C., Li, C., Li, Q., & Xu, X. (2016) · Development Genes and Evolution · doi:10.1007/s00427-016-0561-4 · Cited by 33
A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability
Wang, L., Adamski, C. J., Bondar, V. V., Craigen, E., Collette, J. R., Pang, K., Han, K., Jain, A., Jung, S. Y., Liu, Z., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0325-9 · Cited by 31
Epigenetic alterations in patients with anorexia nervosa—a systematic review
Käver, L., Hinney, A., Rajcsanyi, L. S., Maier, H. B., Frieling, H., Steiger, H., Voelz, C., Beyer, C., Trinh, S., & Seitz, J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02601-w · Cited by 29
Subacute Neuropsychiatric Syndrome in Girls WithSHANK3Mutations Responds to Immunomodulation
Bey, A. L., Gorman, M., Gallentine, W. B., Kohlenberg, T. M., Frankovich, J., Jiang, Y., & van Haren, K. P. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1490 · Cited by 28
Self-citationThe Role of Genetics, Epigenetics, and the Environment in ASD: A Mini Review
Khogeer, A., Abumansour, I. S., & Mohammed, D. A. (2022) · Epigenomes · doi:10.3390/epigenomes6020015 · Cited by 30
SHANK3 conformation regulates direct actin binding and crosstalk with Rap1 signaling
Salomaa, S. I., Miihkinen, M., Kremneva, E., Paatero, I., Lilja, J., Jacquemet, G., Vuorio, J., Antenucci, L., Kogan, K., Nia, F. H., et al. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.022 · Cited by 27
Lahiri, D. K., Maloney, B., Bayon, B. L., Chopra, N., White, F. A., Greig, N. H., & Nürnberger, J. I. (2016) · Epigenomics · doi:10.2217/epi.15.117 · Cited by 26
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice
Sarowar, T., Chhabra, R., Vilella, A., Boeckers, T. M., Zoli, M., & Grabrucker, A. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13709 · Cited by 29
Shorey‐Kendrick, L. E., Roberts, V. H. J., D'Mello, R. J., Sullivan, E. L., Murphy, S. K., McCarty, O. J. T., Schust, D. J., Hedges, J. C., Mitchell, A. J., Terrobias, J. J. D., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01519-4 · Cited by 25
DNA methylation analysis in constitutional disorders: Clinical implications of the epigenome
Schenkel, L. C., Rodenhiser, D. I., Ainsworth, P., Paré, G., & Sadiković, B. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1113496 · Cited by 25
Modeling of Autism Using Organoid Technology
Choi, H. G., Song, J., Park, G., & Kim, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0274-8 · Cited by 24
Bio-collections in autism research
Reilly, J., Gallagher, L., Chen, J. L., Leader, G., & Shen, S. (2017) · Molecular Autism · doi:10.1186/s13229-017-0154-8 · Cited by 23
Neklyudova, A. K., Smirnov, K., Rebreikina, A. B., Martynova, O., & Sysoeva, O. (2022) · Genes · doi:10.3390/genes13040671 · Cited by 22
Epigenetic remodelling and dysregulation of DLGAP4 is linked with early-onset cerebellar ataxia
Minocherhomji, S., Hansen, C., Kim, H., Mang, Y., Bak, M., Guldberg, P., Papadopoulos, N., Eiberg, H., Doh, G. D., Møllgård, K., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu337 · Cited by 20
Constitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors
Schenkel, L. C., Rodenhiser, D. I., Siu, V. M., McCready, E., Ainsworth, P., & Sadiković, B. (2016) · Journal of Pediatric Genetics · doi:10.1055/s-0036-1593849 · Cited by 20
Alex, A. M., Saradalekshmi, K. R., Shilen, N., Suresh, P. A., & Banerjee, M. (2019) · IUBMB Life · doi:10.1002/iub.2021 · Cited by 20
APOE hypermethylation is associated with autism spectrum disorder in a Chinese population
Hu, Z., Yang, Y., Zhao, Y., Yu, H., Ying, X., Zhou, D., Zhong, J. M., Zheng, Z., Liu, J., Pan, R., et al. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6069 · Cited by 18
DNA methylation in adult diffuse gliomas
Leblanc, V., & Marra, M. A. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw019 · Cited by 20
Neklyudova, A. K., Portnova, G. V., Rebreikina, A. B., Voinova, V. Y., Vorsanova, S. G., Iourov, I. Y., & Sysoeva, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041898 · Cited by 21
The Metallome as a Link Between the “Omes” in Autism Spectrum Disorders
Stanton, J. E., Malijauskaite, S., McGourty, K., & Grabrucker, A. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.695873 · Cited by 16
Association of human serotonin receptor 4 promoter methylation with autism spectrum disorder
Hu, Z., Ying, X., Huang, L., Zhao, Y., Zhou, D., Liu, J., Zhong, J. M., Huang, T., Zhang, W., Cheng, F., et al. (2020) · Medicine · doi:10.1097/md.0000000000018838 · Cited by 17
DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target?
Gholamalizadeh, H., Amiri-Shahri, M., Rasouli, F., Ansari, A., Rahimi, V. B., & Askari, V. R. (2024) · Brain Sciences · doi:10.3390/brainsci14080737 · Cited by 18
Jin, C., Kang, H. R., Kang, H., Zhang, Y., Lee, Y., Kim, Y., & Han, K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00228 · Cited by 18
Jeong, J., Yoo, H. J., An, J., & Jeong-Yu, S. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100237 · Cited by 15
Zhou, Q., Tian, Y., Xu, C., Wang, J., & Jin, Y. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01170-x · Cited by 14
Kuodza, G. E., Kawai, R., & LaSalle, J. M. (2024) · Current Zoology · doi:10.1093/eep/dvae023 · Cited by 15
Epigenetic Regulation of Bovine Spermatogenic Cell-Specific Gene Boule
Wang, Y., Li, Y., Li, B., Luo, H., Xu, H., Pan, Z., Xie, Z., & Li, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128250 · Cited by 15
Self-citationGenetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases
Barbé, L., & Finkbeiner, S. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.750629 · Cited by 15
Casanovas, S., Schlichtholz, L., Mühlbauer, S., Dewi, S., Schüle, M., Strand, D. J., Strand, S., Zografidou, L., & Winter, J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00066 · Cited by 14
Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and Shank2-Mutant Mice
Yoo, Y.-E., Lee, S., Kim, W., Kim, H., Chung, C., Ha, S., Park, J., Chung, Y., Kang, H., & Kim, E. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.712576 · Cited by 12
Krsička, D., Géryk, J., Vlčková, M., Havlovičová, M., Maçek, M., & Pourová, R. K. (2017) · Autism Research · doi:10.1002/aur.1780 · Cited by 13
AlOlaby, R. R., Zafarullah, M., Barboza, M., Peng, G., Varian, B. J., Erdman, S. E., Lebrilla, C. B., & Tassone, F. (2022) · Genes · doi:10.3390/genes13081300 · Cited by 13
Epigenetic modulation rescues neurodevelopmental deficits in Syngap1+/− mice
Singh, A. K., Joshi, I., Reddy, N. M. N., Purushotham, S. S., Eswaramoorthy, M., Vasudevan, M., Banerjee, S., Clement, J. P., & Kundu, T. K. (2025) · Aging Cell · doi:10.1111/acel.14408 · Cited by 13
Horizons of psychiatric genetics and epigenetics: where are we and where are we heading?
Abdolmaleky, H. M. (2014) · Europe PMC (PubMed Central) · Cited by 12
Perini, S., Filosi, M., The Italian Autism Network, Allibrio, G., Basadonne, I., Benvenuto, A., Buono, S., Bravaccio, C., Casonato, C., Ceppi, E., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02407-4 · Cited by 14
Wang, Y., Perez‐Rosello, T., Smukowski, S. N., Surmeier, D. J., & Savas, J. N. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02493-w · Cited by 15
The Future of Epigenetics: Emerging Technologies and Clinical Applications
Iyer, K. A., Tenchov, R., Sasso, J. M., Thite, T., Deng, Y., & Zhou, Q. A. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00729 · Cited by 12
Morales-Marín, M. E., Castro-Martínez, X. H., Centeno-Cruz, F., Barajas-Olmos, F. M., López, O. N., Cotero, A. G. G., Orozco, L., & Nicolini, H. (2023) · Brain Sciences · doi:10.3390/brainsci13101420 · Cited by 12
From Tiny Exons to Big Insights: The Expanding Field of Microexons
Mackensen, T., & Irimia, M. (2025) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-121323-103648 · Cited by 10
Zhang, F., Icyuz, M., Tollefsbol, T. O., Cox, P. A., Banack, S. A., & Sun, L. Y. (2022) · Biomedicines · doi:10.3390/biomedicines11010104 · Cited by 9
Zappala, C., Barrios, C. D., & Depino, A. M. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.05.009 · Cited by 10
Role of SHANK3 in concentrated ambient PM2. 5 exposure induced autism-like phenotype
Li, K., Liang, X., Xie, X., Tian, L., Yan, J., Lin, B., Liu, H., Lai, W., Liu, X., & Xi, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14328 · Cited by 10
Freitag, C. M., Chiocchetti, A. G., Haslinger, D., Yousaf, A., & Waltes, R. (2021) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000803 · Cited by 11
Genome-wide DNA methylation profiles of autism spectrum disorder
Sun, L., Wang, X., Wang, X., Cui, X., Li, G., Wang, L., Wang, L., Song, M., & Yu, L. (2022) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000314 · Cited by 9
Self-citationLee, S., Kang, H., Jung, H., Kim, E., & Lee, E. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.683196 · Cited by 9
Lu, X., Ni, P., Suárez-Meade, P., Ma, Y., Forrest, E., Wang, G., Wang, Y., Quiñones‐Hinojosa, A., Gerstein, M., & Jiang, Y.-H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114376 · Cited by 10
Self-citationPhotodynamic Modification of Native HCN Channels Expressed in Thalamocortical Neurons
Wei, F., Wang, Q., Han, J., Goswamee, P., Gupta, A., McQuiston, A. R., Liu, Q., & Zhou, L. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00475 · Cited by 8
Kudryavtseva, N. N., Kovalenko, I. L., Смагин, Д. А., Galyamina, A. G., & Babenko, V. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-804078-2.00014-3 · Cited by 8
Metadata
- Authors
- Zhu, L., Wang, X., Li, X.-L., Towers, A., Cao, X., Wang, P., Bowman, R., Yang, H., Goldstein, J., Li, Y.-J., & Jiang, Y.-H.
- Affiliations
- Duke University (US)
- Corresponding author
- Jiang, Yong-Hui
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-11-01
- Volume
- 23
- Issue
- 6
- Pages
- 1563-1578
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC3929093
- OpenAlex
- W2146527331
- Cited by
- 147
- References
- 71
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 10 · 2023: 16 · 2022: 10 · 2021: 16 · 2020: 11 · 2019: 11 · 2018: 7 · 2017: 8 · 2016: 17 · 2015: 16 · 2014: 9
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Autism Speaks
- National Institute of Mental Health (R01MH098114)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD043494)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- autism spectrum disorder, SHANK3, DNA methylation, epigenetic dysregulation, CpG islands, postmortem brain, alternative splicing, splice variants, DNA methylation inhibitors, biomarkers, gene-environment interaction, ASD etiology
- MeSH terms
- Brain, Child Development Disorders, Pervasive, Exons, Gene Expression Regulation, Humans, Nerve Tissue Proteins, Promoter Regions, Genetic, Alternative Splicing, CpG Islands, DNA Methylation, Protein Isoforms, Epigenesis, Genetic, Cell Line, Tumor, HEK293 Cells, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review